Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases. Academic Article uri icon


  • Fibrosis is a consequence of chronic inflammation and the persistent accumulation of extracellular matrix, for which the cycle of tissue injury and repair becomes a predominant feature. Both the innate and adaptive immune systems play key roles in the progress of fibrosis. The recently identified subsets of innate lymphoid cells (ILCs), which are mainly localize to epithelial surfaces, have been characterized as regulators of chronic inflammation and tissue remodeling, representing a functional bridge between the innate and adaptive immunity. Moreover, recent research has implicated ILCs as potential contributing factors to several kinds of fibrosis diseases, such as hepatic fibrosis and pulmonary fibrosis. Here, we will summarize and discuss the key roles of ILCs and their related factors in fibrotic diseases and their potential for translation to the clinic.

published proceedings

  • Int Rev Immunol

altmetric score

  • 0.25

author list (cited authors)

  • Zhang, Y. i., Tang, J., Tian, Z., van Velkinburgh, J. C., Song, J., Wu, Y., & Ni, B.

citation count

  • 11

complete list of authors

  • Zhang, Yi||Tang, Jun||Tian, Zhiqiang||van Velkinburgh, Jennifer C||Song, Jianxun||Wu, Yuzhang||Ni, Bing

publication date

  • September 2016